biotech
Novartis to Pay Matchpoint up to $1 Billion to Develop Anti-Inflammatory Therapies
NATO Fund Backs Biotech Startup in Push to Counter Biological Threats
BioNTech Takes Over CureVac in $1.25 Billion All-Stock Deal Among Covid Rivals
Merck Held Talks to Buy Biotech MoonLake for Over $3 Billion, Ft Reports
Sanofi to Acquire Vigil Neuroscience in $470 Million Deal
Date: May 22, 2025
(Reuters) -Sanofi said on Thursday that it would acquire Vigil Neuroscience, a clinical-stage biotech company, for $8 per share in cash, valuing the deal at about $470 million. (Reporting by Bipasha...
Swiss Biotech BioVersys Gets $235 Million Valuation After Completing Flotation
Date: February 6, 2025
ZURICH (Reuters) - Swiss biotech BioVersys, which develops treatments for serious infections caused by drug resistant bacteria, has completed its initial public offering with an implied market...
Bavarian Nordic Has $340 Million Orders for Its Mpox, Smallpox Vaccine in 2025
Date: November 16, 2024
STOCKHOLM (Reuters) – Danish biotech Bavarian Nordic said on Friday the order book for delivery of its vaccine for mpox and smallpox in 2025 currently totals around 2.40 billion crowns ($340 million), including previously announced deferred revenue. The World Health Organisation in August declared mpox a global public health emergency for the second time in...
Novavax Cuts 2024 Revenue Forecast Again on Lower Covid Vaccine Sales
Date: November 12, 2024
By Patrick Wingrove (Reuters) -Novavax cut its annual revenue forecast on Tuesday, citing lower-than-expected sales of its COVID-19 vaccine, ahead of handing over the rights to sell the shot to French drugmaker Sanofi. Shares of the U.S. biotech firm dropped about 8.2% to $8.28 in premarket trading. The U.S. vaccine maker now expects between $175...
Finding the Next Big Impact Investing Opportunity in the UK Biotech Sector
Date: May 15, 2023
Finding the next big impact investing opportunity in the UK biotech sector By Alexandra Martinez, Co-Founder and Chief Visionary Officer of Clota Värde The global burden of Alzheimer’s disease is staggering. With over 55 million people across the world affected by dementia-related neurodegeneration, and one in three people born in the UK this year developing...
New Tax Credit Scheme a Lifeline for British Biotech, Say Execs
Date: March 16, 2023
By Natalie Grover LONDON (Reuters) – Britain’s budget has offered a shot in the arm to research-intensive biotech and life-sciences sector, company executives said on Wednesday, as the government seeks to put the industry in the global vanguard. Finance minister Jeremy Hunt said if 40% or more of expenditure of small and medium-sized enterprises (SMEs)...